Pharma

Vertex Pharmaceuticals CEO Reshma Kewalramani Honored with the Lifetime Achievement Award 2024

November 21, 2024

Accelerating Climate Action, 11 Boston and Cambridge Institutions Collaborate to Invest in Wind and Solar Power

November 20, 2024

Lumicell’s Board of Directors Appoints Howard Hechler as Chief Executive Officer

November 13, 2024

THIS WEEK'S STORIES

TRIO Pharmaceuticals Completes $3.1 Million Financing Round to Advance Cancer Therapeutics Pipeline

December 3, 2024

FairJourney Biologics Appoints Dr. Marc van Dijk as Chief Scientific Officer of Antibody Discovery and Engineering

December 4, 2024

Aya Healthcare to Acquire Cross Country Healthcare for Approximately $615 Million in Cash

December 4, 2024

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Sudo Biosciences Announces First Participants Dosed in Phase 1 Trial of Brain-Penetrant Allosteric TYK2 Inhibitor SUDO-550

Precision BioSciences Highlights Preclinical Data and Outlines Design of First-in-Human Clinical Trial for PBGENE-HBV for Treatment of Chronic Hepatitis B

Aptar Pharma Enters into Exclusive Agreement with Cambridge Healthcare Innovations to Commercialize the Quattrii Dry Powder Inhaler Platform

Scripps Research Advances Breakthrough Regenerative Medicines to Reverse Aging-Related Diseases

Bayer and Liveo Research Launch First-of-its-Kind Blister Packaging with Improved Environmental Footprint

Most Read

Aya Healthcare to Acquire Cross Country Healthcare for Approximately $615 Million in Cash

DocGo Signs Contract in Mississippi with Major Hospital System to Provide Adult and Pediatric Remote Cardiac Monitoring Services

Carlsmed Announces FDA Clearance for aprevo® Cervical Breakthrough Fusion Device

Thermo Fisher Scientific Launches CTS Detachable Dynabeads CD4 and CTS Detachable Dynabeads CD8 to Enhance Cell Therapy Development and Production

EDITOR PICKS

Vertex Pharmaceuticals CEO Reshma Kewalramani Honored with the Lifetime Achievement Award 2024

Accelerating Climate Action, 11 Boston and Cambridge Institutions Collaborate to Invest in Wind and Solar Power

Lumicell’s Board of Directors Appoints Howard Hechler as Chief Executive Officer

THIS WEEK'S STORIES

TRIO Pharmaceuticals Completes $3.1 Million Financing Round to Advance Cancer Therapeutics Pipeline

FairJourney Biologics Appoints Dr. Marc van Dijk as Chief Scientific Officer of Antibody Discovery and Engineering

Aya Healthcare to Acquire Cross Country Healthcare for Approximately $615 Million in Cash

POPULAR CATEGORY

ABOUT US

FOLLOW US